20th Jul 2016 07:00
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||||||||||||||||||||||
a) | Name | Ms E Walmsley | ||||||||||||||||||||||||||
b) | Position/status | CEO, GSK Consumer Healthcare | ||||||||||||||||||||||||||
c) | Initial notification/ amendment | Initial notification | ||||||||||||||||||||||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||||||||||||
a) | Name | GlaxoSmithKline plc | ||||||||||||||||||||||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||||||||||||||||||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||||||||||||||||||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 | ||||||||||||||||||||||||||
b) | Nature of the transaction | Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
| ||||||||||||||||||||||||||
c) | Price(s) and volume(s) |
| ||||||||||||||||||||||||||
d) | Aggregated information
Aggregated volume Price |
1,263.154 £16.285
| ||||||||||||||||||||||||||
e) | Date of the transaction | 2016-07-14 | ||||||||||||||||||||||||||
f) | Place of the transaction
| n/a | ||||||||||||||||||||||||||
Related Shares:
Glaxosmithkline